Acute kidney injury: Specific interventions and drugs

Management of Acute Kidney Problems

Volumn , Issue , 2010, Pages 229-239

  Prowle, John R ^a   Bellomo, Rinaldo ^a  

^a AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649684209     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-69441-0_24     Document Type: Chapter

References (71)

1. Mueller, C., Buerkle, G., Buettner, H. J., Petersen, J., et al. Prevention of contrast media-Associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162, 329-336 (2002
2. Rudnick, M. R., Goldfarb, S., Wexler, L., Ludbrook, P. A., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative Study. Kidney Int 47, 254-261 (1995
3. Richer, M., Robert, S. & Lebel, M. Renal hemodynamics during norepinephrine and low-Dose dopamine infusions in man. Crit Care Med 24, 1150-1156 (1996
4. Gare, M., Haviv, Y. S., Ben-Yehuda, A., Rubinger, D., et al. The renal effect of low-Dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 34, 1682-1688 (1999
5. Lassnigg, A., Donner, E., Grubhofer, G., Presterl, E., et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11, 97-104 (2000
6. Allaqaband, S., Tumuluri, R., Malik, A. M., Gupta, A., et al. Prospective randomized study of N-Acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 57, 279-283 (2002
7. Stone, G. W., McCullough, P. A., Tumlin, J. A., Lepor, N. E., et al. Fenoldopam mesylate for the prevention of contrastinduced nephropathy: A randomized controlled trial. JAMA 290, 2284-2291 (2003
8. Bove, T., Landoni, G., Calabrò, M. G., Aletti, G., et al. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: A prospective, double-blind, randomized clinical trial. Circulation 111, 3230-3235 (2005
9. Kurnik, B. R., Allgren, R. L., Genter, F. C., Solomon, R. J., et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31, 674-680 (1998
10. Wang, A., Holcslaw, T., Bashore, T. M., Freed, M. I., et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57, 1675-1680 (2000
11. Ix, J. H., McCulloch, C. E. & Chertow, G. M. Theophylline for the prevention of radiocontrast nephropathy: A metaanalysis. Nephrol Dial Transplant 19, 2747-2753 (2004
12. Solomon, R., Werner, C., Mann, D., D'Elia, J. & Silva, P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331, 1416-1420 (1994
13. Tepel, M., Van Der Giet, M., Schwarzfeld, C., Laufer, U., et al. Prevention of radiographic-contrast-Agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343, 180-184 (2000
14. Briguori, A., Colombo, A., Violante, P., Balestrieri, F., Manganelli, P., Paolo Elia, B., Golia, S., Lepore, G., Riviezzo, P., Scarpato, A., Focaccio, M., Librera, E., Bonizzoni, B., Ricciardelli, B. Standard vs double dose of N-Acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J. 25, 206-211 (2004
15. Webb, J. G., Pate, G. E., Humphries, K. H., Buller, C. E., et al. A randomized controlled trial of intravenous N-Acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effect. Am Heart J 148, 422-429 (2004
16. Liu, R., Nair, D., Ix, J., Moore, D. H. & Bent, S. N-Acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-Analysis. J Gen Intern Med 20, 193-200 (2005
17. Bagshaw, S. M. & Ghali, W. A. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-Analysis. BMC Med 2, 38 (2004
18. Vaitkus, P. T. & Brar, C. N-Acetylcysteine in the prevention of contrast-induced nephropathy: Publication bias perpetuated by meta-Analyses. Am Heart J 153, 275-280 (2007
19. Gonzales, D. A., Norsworthy, K. J., Kern, S. J., Banks, S., et al. A meta-Analysis of N-Acetylcysteine in contrast-induced nephrotoxicity: Unsupervised clustering to resolve heterogeneity. BMC Med 5, 32 (2007
20. Zagler, A., Azadpour, M., Mercado, C. & Hennekens, C. H. N-Acetylcysteine and contrast-induced nephropathy: A metaanalysis of 13 randomized trials. Am Heart J 151, 140-145 (2006
21. Bagshaw, S. M., McAlister, F. A., Manns, B. J. & Ghali, W. A. Acetylcysteine in the prevention of contrast-induced nephropathy: A case study of the pitfalls in the evolution of evidence. Arch Intern Med 166, 161-166 (2006
22. Alonso, A., Lau, J., Jaber, B. L., Weintraub, A. & Sarnak, M. J. Prevention of radiocontrast nephropathy with N-Acetylcysteine in patients with chronic kidney disease: A meta-Analysis of randomized, controlled trials. Am J Kidney Dis 43, 1-9 (2004
23. Pannu, N., Manns, B., Lee, H. & Tonelli, M. Systematic review of the impact of N-Acetylcysteine on contrast nephropathy. Kidney Int 65, 1366-1374 (2004
24. Isenbarger, D. W., Kent, S. M. & O'Malley, P. G. Metaanalysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 92, 1454-1458 (2003
25. Birck, R., Krzossok, S., Markowetz, F., Schnülle, P., et al. Acetylcysteine for prevention of contrast nephropathy: Meta-Analysis. Lancet 362, 598-603 (2003
26. Hoffmann, U., Fischereder, M., Krüger, B., Drobnik, W. & Krämer, B. K. The value of N-Acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15, 407-410 (2004
27. Haase, M., Haase-Fielitz, A., Ratnaike, S., Reade, M. C., et al. N-Acetylcysteine does not artifactually lower plasma creatinine concentration. Nephrol Dial Transplant (2008
28. Khanal, S., Attallah, N., Smith, D. E., Kline-Rogers, E., et al. Statin therapy reduces contrast-induced nephropathy: An analysis of contemporary percutaneous interventions. Am J Med 118, 843-849 (2005
29. Chello, M., Mastroroberto, P., Patti, G., D'Ambrosio, A., et al. Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart 89, 538-543 (2003
30. Chello, M., Carassiti, M., Agrò, F., Mastroroberto, P., et al. Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 18, 605-609 (2004
31. Chello, M., Goffredo, C., Patti, G., Candura, D., et al. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. Eur J Cardiothorac Surg 28, 805-810 (2005
32. Gueler, F., Rong, S., Park, J. K., Fiebeler, A., et al. Postischemic acute renal failure is reduced by short-Term statin treatment in a rat model. J Am Soc Nephrol 13, 2288-2298 (2002
33. Inman, S. R., Davis, N. A., Olson, K. M. & Lukaszek, V. A. Simvastatin attenuates renal ischemia/reperfusion injury in rats administered cyclosporine A. Am J Med Sci 326, 117-121 (2003
34. Inman, S. R., Davis, N. A., Mazzone, M. E., Olson, K. M., et al. Simvastatin and L-Arginine preserve renal function after ischemia/reperfusion injury. Am J Med Sci 329, 13-17 (2005
35. Yokota, N., O'Donnell, M., Daniels, F., Burne-Taney, M., et al. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol 23, 13-17 (2003
36. Vogt, B., Ferrari, P., Schönholzer, C., Marti, H. P., et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111, 692-698 (2001
37. Marenzi, G., Marana, I., Lauri, G., Assanelli, E., et al. The prevention of radiocontrast-Agent-induced nephropathy by hemofiltration. N Engl J Med 349, 1333-1340 (2003
38. Finfer, S., Bellomo, R., Boyce, N., French, J., et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350, 2247-2256 (2004
39. Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resusciation in severe sepsis. New Engl J Med 358, 125-139 (2008
40. Martin, C., Papazian, L., Perrin, G., Saux, P. & Gouin, F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103, 1826-1831 (1993
41. Kohli, H. S., Bhaskaran, M. C., Muthukumar, T., Thennarasu, K., et al. Treatment-related acute renal failure in the elderly: A hospital-based prospective study. Nephrol Dial Transplant 15, 212-217 (2000
42. Bourgoin, A., Leone, M., Delmas, A., Garnier, F., et al. Increasing mean arterial pressure in patients with septic shock: Effects on oxygen variables and renal function. Crit Care Med 33, 780-786 (2005
43. Kellum, J. A. & M Decker, J. Use of dopamine in acute renal failure: A meta-Analysis. Crit Care Med 29, 1526-1531 (2001
44. Bellomo, R., Chapman, M., Finfer, S., Hickling, K. & Myburgh, J. Low-Dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356, 2139-2143 (2000
45. Morelli, A., Ricci, Z., Bellomo, R., Ronco, C., et al. Prophylactic fenoldopam for renal protection in sepsis: A randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33, 2451-2456 (2005
46. Landoni, G., Biondi-Zoccai, G. G., Tumlin, J. A., Bove, T., et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: A meta-Analysis of randomized clinical trials. Am J Kidney Dis 49, 56-68 (2007
47. Aravindan, N., Natarajan, M. & Shaw, A. D. Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischemic acute renal failure. J Cardiothorac Vasc Anesth 20, 179-186 (2006
48. Mehta, R. L., Pascual, M. T., Soroko, S., Chertow, G. M. & PICARD Study Group Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288, 2547-2553 (2002
49. Uchino, S., Doig, G. S., Bellomo, R., Morimatsu, H., et al. Diuretics and mortality in acute renal failure. Crit Care Med 32, 1669-1677 (2004
50. Bagshaw, S. M., Delaney, A., Haase, M., Ghali, W. A. & Bellomo, R. Loop diuretics in the management of acute renal failure: A systematic review and meta-Analysis. Crit Care Resusc 9, 60-68 (2007
51. Bonventre, J. V. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11, 43-48 (2002
52. Bernard, S. A., Gray, T. W., Buist, M. D., Jones, B. M., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346, 557-563 (2002
53. Hypothermia after Cardiac Arrest Study Group Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346, 549-556 (2002
54. Acker, C. G., Singh, A. R., Flick, R. P., Bernardini, J., et al. A trial of thyroxine in acute renal failure. Kidney Int 57, 293-298 (2000
55. Hirschberg, R., Kopple, J., Lipsett, P., Benjamin, E., et al. Multicenter clinical trial of recombinant human insulin-Like growth factor I in patients with acute renal failure. Kidney Int 55, 2423-2432 (1999
56. Van Den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345, 1359-1367 (2001
57. Van Den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354, 449-461 (2006
58. Yamada, K., Miwa, T., Liu, J., Nangaku, M. & Song, W. C. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 172, 3869-3875 (2004
59. Singbartl, K. & Ley, K. Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin. Crit Care Med 28, 2507-2514 (2000
60. Singbartl, K., Green, S. A. & Ley, K. Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 14, 48-54 (2000
61. Kelly, K. J., Williams, W. W., Colvin, R. B. & Bonventre, J. V. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91, 812-816 (1994
62. Bernard, G. R., Vincent, J. L., Laterre, P. F., LaRosa, S. P., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344, 699-709 (2001
63. Lenz, K., Hörtnagl, H., Druml, W., Grimm, G., et al. Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. Gut 30, 90-96 (1989
64. Guevara, M., Ginès, P., Fernández-Esparrach, G., Sort, P., et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27, 35-41 (1998
65. Hadengue, A., Gadano, A., Moreau, R., Giostra, E., et al. Beneficial effects of the 2-Day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 29, 565-570 (1998
66. Uriz, J., Ginès, P., Cárdenas, A., Sort, P., et al. Terlipressin plus albumin infusion: An effective and safe therapy of hepatorenal syndrome. J Hepatol 33, 43-48 (2000
67. de Laet, I. E. & Malbrain, M. Current insights in intraabdominal hypertension and abdominal compartment syndrome. Med Intensiva 31, 88-99 (2007
68. De Waele, J. J., Hoste, E. A. & Malbrain, M. L. Decompressive laparotomy for abdominal compartment syndrome-A critical analysis. Crit Care 10, R51 (2006
69. Holt, S. G. & Moore, K. P. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med 27, 803-811 (2001
70. Naka, T., Jones, D., Baldwin, I., Fealy, N., et al. Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: A case report. Crit Care 9, R90-R95 (2005
71. Bagshaw, S. M. & Bellomo, R. Early diagnosis of acute kidney injury. Curr Opin Crit Care 13, 638-644 (2007